Biologics are currently available for asthma management and being studied ... in the treatment algorithm for patients with type 2 inflammation-driven COPD? How does the route of administration ...

Panelists discuss how type 2 inflammatory diseases, such as asthma, atopic dermatitis, and chronic rhinosinusitis, can significantly impair patients’ quality of life through persistent symptoms ...

Two years later, she became the first paediatric patient to be offered a form of treatment called CAR-T, in which the body’s ...

Reserved for members of the media. A Saint Louis University School of Medicine researcher says Type 2 inflammation, typically associated with allergies and asthma, is a risk factor for developing ...

Asthma is classically considered a disorder of the immune system. People with the disease typically show a T helper type 2 (T H 2) type inflammatory profile, indicative of overactive allergic ...

The US Food and Drug Administration has approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic ...

The type-2 low subtype includes both neutrophilic and paucigranulocytic asthma, the latter of which ... contribute to treatment-refractory neutrophilic inflammation caused by type-1 cytokine ...

Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Dupixent is indicated for the approximately ...

Type-2 helper T (Th2) cells play intricate roles in the inflammatory response underlying asthma. Elevated levels of the protein GATA3 stimulate the maturation of these cells. Consequently ...

Objective To examine whether a heat- and moisture-exchanging breathing device (HME) attenuates release of Type-2 inflammatory biomarkers into the airways following an exercise challenge in sub-zero ...

Commonly known as the Insulin plant, Costus igenus belongs to the Costaceae family, and its consumption is said to lower ...

The data from the real-world evidence study "Characterizing uncontrolled severe asthma in Canada (ALERT)" was recently ...